From Sophie Spitz to Molecular Melanocytoma

How one woman's pioneering research transformed pediatric melanoma diagnosis

1

Sophie Spitz's 1948 paper introduced the term 'juvenile melanoma,' highlighting benign lesions that appeared alarming under the microscope.
2

Spitz nevi, named in honor of Sophie Spitz, were recognized as typically benign despite challenges in distinguishing them from melanoma.
3

Molecular discoveries, including HRAS mutations and kinase fusions, have advanced the classification of Spitz lesions over the decades.
4

Spitz's research transformed pediatric melanoma diagnosis, changing treatment standards and sparing children from unnecessary interventions.
5

Sophie Spitz's legacy endures as a pioneering female scientist who significantly impacted dermatopathology before her untimely death at age 46.

1